With the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this population are growing yet often poorly understood and addressed.
Jul 3, 2024
0
0
A novel approach for early cancer treatment known as radioligand therapy (RLT) has been shown to significantly reduce the risk of advanced neuroendocrine tumor progression and death, according to research led by scientists ...
Jul 2, 2024
0
73
Researchers in the Division of Orthopedics and Sports Medicine and Performance Center at Children's Hospital of Philadelphia (CHOP) announced results from a large retrospective study of patients surgically treated for patellar ...
Jul 2, 2024
0
0
Cancer treatments often cause nerve damage that can lead to long-lasting symptoms. Medication has proven ineffective in these cases. A sports scientist at the University of Basel, together with an interdisciplinary team from ...
Jul 1, 2024
0
26
An international research team has demonstrated a method to identify the cells in the immune system that can recognize and fight cancer cells in samples from 9 out of 10 patients affected by the rare but aggressive form of ...
Jul 1, 2024
0
5
Patients living in "high-sun" climates may require higher doses of Botox to achieve good results in cosmetic treatment of facial lines and wrinkles, reports a study in the July issue of Plastic and Reconstructive Surgery.
Jul 1, 2024
0
1
A year of treatment with a medicine made of an antibody and chemotherapy drug has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring in patients, a team led by Dana-Farber Cancer Institute ...
Jun 27, 2024
0
0
A new study from Karolinska Institutet shows that 45 genes may play a crucial role in the prognosis of patients with adrenal cancer. The findings, published in the journal ESMO Open, give hope for a better diagnostic tool ...
Jun 27, 2024
0
0
Patients with a genetic syndrome called NF2-related schwannomatosis (NF2-SWN) have tumors that develop on the covering of the brain or grow along the nerves in the brain, spinal cord, and/or other locations in the body.
Jun 24, 2024
0
18
The U.S. Food and Drug Administration has expanded indications for AbbVie's Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic ...
Jun 24, 2024
0
0
